Changchun BCHT Biotechnology Co. A

SHG:688276 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.06 Billion
CN¥7.78 Billion CNY
Market Cap Rank
#12973 Global
#3279 in China
Share Price
CN¥18.81
Change (1 day)
-0.58%
52-Week Range
CN¥18.53 - CN¥25.44
All Time High
CN¥117.52
About

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 200… Read more

Changchun BCHT Biotechnology Co. A - Asset Resilience Ratio

Latest as of June 2020: 5.98%

Changchun BCHT Biotechnology Co. A (688276) has an Asset Resilience Ratio of 5.98% as of June 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥120.00 Million
Cash + Short-term Investments
Total Assets
CN¥2.01 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Changchun BCHT Biotechnology Co. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Changchun BCHT Biotechnology Co. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥120.00 Million 5.98%
Total Liquid Assets CN¥120.00 Million 5.98%

Asset Resilience Insights

  • Limited Liquidity: Changchun BCHT Biotechnology Co. A maintains only 5.98% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Changchun BCHT Biotechnology Co. A Industry Peers by Asset Resilience Ratio

Compare Changchun BCHT Biotechnology Co. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Changchun BCHT Biotechnology Co. A (None–None)

The table below shows the annual Asset Resilience Ratio data for Changchun BCHT Biotechnology Co. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points